Héctor de Lucio

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 4

Top Topics

Perovskite Solar Cells

Tissue Engineering

Top Venues

ACS infectious diseases

Journal of medicinal chemistry

Pharmaceuticals (Basel, Switzerland)

British journal of pharmacology

Universidad de Alcalá

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidad de Alcalá

Spain

Investigador Postdoctoral :: Departamento de Biología de Sistemas

Publications

Alejandro Revuelto, Héctor de Lucio, Juan Carlos García-Soriano, Pedro A Sánchez-Murcia, Federico Gago, Antonio Jiménez-Ruiz, Maria-Jose Camarasa, Sonsoles Velázquez
Efficient Dimerization Disruption of Leishmania infantum Trypanothione Reductase by Triazole-phenyl-thiazoles. Journal of medicinal chemistry 64 (9) (2021)
Alejandro Revuelto, Isabel López-Martín, Héctor de Lucio, Juan Carlos García-Soriano, Nicola Zanda, Sonia de Castro, Federico Gago, Antonio Jiménez-Ruiz, Sonsoles Velázquez, Maria-Jose Camarasa
Small Molecule-Peptide Conjugates as Dimerization Inhibitors of Leishmania infantum Trypanothione Disulfide Reductase. Pharmaceuticals (Basel, Switzerland) 14 (7) (2021)
Héctor de Lucio, Miguel A Toro, María-José Camarasa, Sonsoles Velázquez, Federico Gago, Antonio Jiménez-Ruiz
Pseudoirreversible slow-binding inhibition of trypanothione reductase by a protein-protein interaction disruptor. British journal of pharmacology 177 (22) (2020)
Alejandro Revuelto, Marta Ruiz-Santaquiteria, Héctor de Lucio, Ana Gamo, Alejandra Angela Carriles, Kilian Jesús Gutiérrez, Pedro A Sánchez-Murcia, Juan A Hermoso, Federico Gago, Maria-Jose Camarasa, Antonio Jiménez-Ruiz, Sonsoles Velázquez
Pyrrolopyrimidine vs Imidazole-Phenyl-Thiazole Scaffolds in Nonpeptidic Dimerization Inhibitors of Leishmania infantum Trypanothione Reductase. ACS infectious diseases 5 (6) (2019)